Skip to Main Content

Advertisement

Skip Nav Destination

Bleeding Disorders

December 20, 2021

A collection of features and news articles published in ASH Clinical News related to bleeding disorders.

Keywords:

Fitusiran Reduces Bleeding Risk in Patients With Hemophilia A or B Without Inhibitors

Once-monthly prophylactic treatment with subcutaneous fitusiran reduced the risk of bleeding in patients with severe hemophilia A or B without inhibitors, compared with once-daily...

Adding All-Trans Retinoic Acid to Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

A combination regimen comprising all-trans retinoic acid (ATRA) plus low-dose rituximab was associated with an 80% overall response rate and a 61% sustained...

How Safe Is Vaccination Against SARS-CoV-2 for Patients With De Novo and Preexisting ITP?

A report describing the effects of SARS-CoV-2 vaccination on platelet counts of patients with de novo and preexisting immune thrombocytopenia (ITP), including findings of...

Mycophenolate Mofetil Plus Glucocorticoid Reduces Relapse Risk in ITP

Initial treatment with mycophenolate mofetil plus a glucocorticoid was associated with a greater response and reduced risk of relapsed or refractory disease compared with...

Emicizumab Improves Bleeding Prophylaxis in Patients With Acquired Hemophilia A

The FVIII-mimetic bispecific antibody emicizumab could provide effective and safe outpatient prophylaxis in patients with acquired hemophilia A (AHA), according to results of a study presented during the 2021 ASH Annual...

Advertisement

  CURRENT ISSUE
  Mid-January 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X